Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia.
S ChandrakalaManoj ToshniwalMitesh HalvawalaNamita PadwalNeeraj SidharthanPankaj MalhotraB PrashanthaRiya BallikarSandip ShahShashikant ApteT Kasi ViswanathanVijay RamananAkhilesh SharmaDattatray PawarRoshan PawarVinayaka ShahaviPublished in: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion (2023)
[This corrects the article DOI: 10.1007/s12288-022-01602-5.].
Keyphrases